14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.87 $1.46 Thursday, 2nd May 2024 ADAP stock ended at $1.19. This is 1.65% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 6.84% from a day low at $1.17 to a day high of $1.25.
90 days $0.87 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Feb 21, 2023 $1.71 $1.71 $1.55 $1.57 155 855
Feb 17, 2023 $1.71 $1.77 $1.66 $1.71 130 252
Feb 16, 2023 $1.63 $1.72 $1.63 $1.71 190 860
Feb 15, 2023 $1.65 $1.67 $1.57 $1.65 188 180
Feb 14, 2023 $1.55 $1.69 $1.55 $1.66 247 755
Feb 13, 2023 $1.63 $1.63 $1.51 $1.55 365 454
Feb 10, 2023 $1.67 $1.74 $1.61 $1.65 347 740
Feb 09, 2023 $1.68 $1.76 $1.67 $1.68 165 081
Feb 08, 2023 $1.69 $1.72 $1.63 $1.68 126 241
Feb 07, 2023 $1.64 $1.69 $1.62 $1.65 103 541
Feb 06, 2023 $1.64 $1.74 $1.63 $1.64 135 580
Feb 03, 2023 $1.74 $1.74 $1.64 $1.66 309 058
Feb 02, 2023 $1.75 $1.81 $1.69 $1.73 236 304
Feb 01, 2023 $1.90 $1.90 $1.71 $1.74 233 668
Jan 31, 2023 $1.86 $1.95 $1.85 $1.87 182 582
Jan 30, 2023 $1.80 $1.92 $1.80 $1.86 437 953
Jan 27, 2023 $1.77 $1.86 $1.75 $1.80 258 149
Jan 26, 2023 $1.86 $1.94 $1.77 $1.77 476 465
Jan 25, 2023 $1.85 $1.87 $1.79 $1.84 208 068
Jan 24, 2023 $1.72 $1.97 $1.72 $1.86 332 912
Jan 23, 2023 $1.71 $1.80 $1.65 $1.75 232 289
Jan 20, 2023 $1.63 $1.73 $1.58 $1.71 277 400
Jan 19, 2023 $1.68 $1.69 $1.59 $1.61 323 200
Jan 18, 2023 $1.75 $1.81 $1.69 $1.71 315 400
Jan 17, 2023 $1.89 $1.94 $1.73 $1.75 581 414
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT